Narirutin exerts anti‐inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Myong Hak Ri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Molecular Medicine Research Center, College of Pharmacy, Yanbian…. Hauptthemen laut MEDLINE: Flavanones, Colitis, Peritonitis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yanbian University Doctoral Research Fund Project, The Jilin Province Science and Technology Development Plan Project.
Abstract (Originalsprache)
Citrus peel has long been used in traditional medicine in Asia to treat common cold, dyspepsia, cough, and phlegm. Narirutin–a flavanone‐7‐O‐glycoside–is the major flavonoid in citrus peel, and has anti‐oxidative, anti‐allergic, and anti‐inflammatory activities. However, the anti‐inflammatory mechanism of narirutin has not been fully elucidated. This study is aimed to investigate the effects of narirutin on the Nod‐like receptor protein 3 (NLRP3)‐mediated inflammatory response in vitro and in vivo, and determine the underlying mechanism. THP‐1 differentiated macrophages and bone marrow‐derived macrophages (BMDMs) were used for in vitro experiments, while dextran sulfate sodium (DSS)‐induced colitis and alum‐induced peritonitis mouse models were constructed to test inflammation in vivo. Narirutin suppressed secretion of interleukin (IL)‐1β and pyroptosis in lipopolysaccharide (LPS)/ATP‐stimulated macrophages. Narirutin decreased the expression of NLRP3 and IL‐1β in the LPS‐priming step through inhibition of NF‐κB, MAPK and PI3K /AKT signaling pathways. Narirutin inhibited NLRP3–ASC interaction to suppress NLRP3 inflammasome assembly. Furthermore, oral administration of narirutin (300 mg/kg) alleviated inflammation symptoms in mice with peritonitis and colitis. These results suggest that narirutin exerts its anti‐inflammatory activity by suppressing NLRP3 inflammasome activation via inhibition of the NLRP3 inflammasome priming processes and NLRP3–ASC interaction in macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Molecular Medicine Research Center, College of Pharmacy, Yanbian University, Yanji, China.
- Faculty of Life Science, Kim Il Sung University, Pyongyang, Democratic People's Republic of Korea.
ORCID-Profile: Xuejun Jin
Förderung
- National Natural Science Foundation of China
- Yanbian University Doctoral Research Fund Project
- The Jilin Province Science and Technology Development Plan Project
- the Education Department of Jilin Province Project
- the Higher Education Discipline Innovation Project
Zitieren
APA
Ri, M. H., Li, M. Y., Xing, Y., Zuo, H. X., Li, G., Li, C., Ma, J., & Jin, X. (2023). Narirutin exerts anti‐inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages. Phytotherapy Research. https://doi.org/10.1002/ptr.7686
Vancouver
Ri MH, Li MY, Xing Y, Zuo HX, Li G, Li C, et al. Narirutin exerts anti‐inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages. Phytotherapy Research. 2023. doi:10.1002/ptr.7686
BibTeX
@article{Ri2023,
author = {Ri, Myong Hak and Li, Ming Yue and Xing, Yue and Zuo, Hong Xiang and Li, Guangyi and Li, Chengcheng and Ma, Juan and Jin, Xuejun},
title = {Narirutin exerts anti‐inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7686}
}
EUVIMED